Kendra Adams
Director of Finance/CFO bei C4 THERAPEUTICS, INC.
Vermögen: 670 259 $ am 31.03.2024
Profil
Kendra R.
Adams is currently the Chief Financial Officer & Treasurer at C4 Therapeutics, Inc. She previously worked as the Director-Investor Relations at ARIAD Pharmaceuticals, Inc. and as the VP-External Communications & Investor Relations at Agios Pharmaceuticals, Inc. Ms. Adams completed her undergraduate degree at Hamilton College (New York).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
C4 THERAPEUTICS, INC.
0,12% | 07.03.2024 | 82 039 ( 0,12% ) | 670 259 $ | 31.03.2024 |
Aktive Positionen von Kendra Adams
| Unternehmen | Position | Beginn |
|---|---|---|
| C4 THERAPEUTICS, INC. | Director of Finance/CFO | 18.09.2023 |
Ehemalige bekannte Positionen von Kendra Adams
| Unternehmen | Position | Ende |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Investor Relations Contact | - |
| ARIAD PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Ausbildung von Kendra Adams
| Hamilton College (New York) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
